Kestra Medical Technologies, Ltd. (KMTS) cash on hand
Kestra Medical Technologies, Ltd. (KMTS) held cash of $196.43M at the end of fiscal 2026 (April 30, 2026). That is 17.3% lower than the $237.60M of fiscal 2025. Figures as of 18 Nov 2026, 12:42 UTC, from Yahoo Finance.
Key facts
- Cash, fiscal 2026
- $196.43M
- Change on fiscal 2025
- −17.3%
- Highest on record
- $237.60Mfiscal 2025
- Lowest on record
- $8.25Mfiscal 2024
- Fiscal years on record
- 42023–2026
Figures as of . Statements from Yahoo Finance. Amounts are in USD. Figures, not advice.
Kestra Medical Technologies, Ltd. cash on hand, in more detail
Across the 4 fiscal years on record (2023–2026), the highest was $237.60M in fiscal 2025 and the lowest $8.25M in fiscal 2024.
Cash by fiscal year
Kestra Medical Technologies, Ltd. cash on hand, year by year
| Fiscal year | Cash | Change | Year ended |
|---|---|---|---|
| 2026 | $196.43M | 17.3% down | |
| 2025 | $237.60M | 2,780.3% up | |
| 2024 | $8.25M | 44.3% down | |
| 2023 | $14.81M | — |
Change is on the fiscal year before; a dash means that year is not on record or the earlier figure was not positive. A dash anywhere else means the figure was not reported or cannot be computed — it is never filled in.
How it is calculated
Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone.
How to read it
Cash is the cushion that pays for bad years, buybacks and acquisitions; compare it with total debt to see whether the company is a net borrower.
Kestra Medical Technologies, Ltd., figure by figure
- Kestra Medical Technologies, Ltd. market cap
- Kestra Medical Technologies, Ltd. revenue
- Kestra Medical Technologies, Ltd. earnings
- Kestra Medical Technologies, Ltd. earnings per share (EPS)
- Kestra Medical Technologies, Ltd. P/E ratio
- Kestra Medical Technologies, Ltd. P/S ratio
- Kestra Medical Technologies, Ltd. P/B ratio
- Kestra Medical Technologies, Ltd. free cash flow
- Kestra Medical Technologies, Ltd. operating margin
- Kestra Medical Technologies, Ltd. dividend
- Kestra Medical Technologies, Ltd. shares outstanding
- Kestra Medical Technologies, Ltd. total debt
- Kestra Medical Technologies, Ltd. total assets
- Kestra Medical Technologies, Ltd. return on equity (ROE)
- Kestra Medical Technologies, Ltd. return on invested capital (ROIC)
Kestra Medical Technologies, Ltd. (KMTS) overview: price, valuation and scorecard
Kestra Medical Technologies, Ltd. cash on hand: questions and answers
How much cash does Kestra Medical Technologies, Ltd. have?
Kestra Medical Technologies, Ltd. (KMTS) held cash of $196.43M at the end of fiscal 2026 (April 30, 2026). That is 17.3% lower than the $237.60M of fiscal 2025.
What are the highest and lowest cash figures on record for Kestra Medical Technologies, Ltd.?
Across the 4 fiscal years on record (2023–2026), the highest was $237.60M in fiscal 2025 and the lowest $8.25M in fiscal 2024.
How is Kestra Medical Technologies, Ltd.'s cash calculated?
Cash is the cash, cash equivalents and short-term investments on the balance sheet at the fiscal year-end, shown for the fiscal years the market data feed covers because the older SEC record counts cash and equivalents alone. For Kestra Medical Technologies, Ltd. it is on record here for 4 fiscal years, 2023 to 2026.
Fiscal years are named for the calendar year they end in.
Learn: cash on hand
All stocks guides →- Altman Z-score: formula, zones and where it fails
The Altman Z-score is a weighted sum of five financial ratios that Edward Altman fitted in 1968 to separate companies that went bankrupt from those that did not. Funkfolio reads above 2.99 as the safe zone, below 1.81 as the distress zone, and between them a grey zone. It does not suit banks or insurers.
- Market cap vs enterprise value: what is the difference?
Market capitalization is the value of a company's shares. Enterprise value is market cap plus debt, minus cash: roughly what it would cost to buy the whole business and settle its borrowings. Two companies with the same $50 billion market cap can have very different enterprise values if one owes $20 billion and the other holds $20 billion in cash.
- Analyst price targets and ratings: what they mean
An analyst price target is a research analyst's estimate of where a share price will be at a set horizon, such as twelve months; a rating such as buy or hold is that analyst's recommendation. A consensus is an average or median of the targets a data provider has collected. Studies have found targets on average well above later prices.
Cite this page
Funkfolio, “Kestra Medical Technologies, Ltd. (KMTS) cash on hand”, data as of 18 November 2026. https://funkfolio.com/stock/KMTS/cash
Underlying data: Yahoo Finance.